Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View

Dr. Christin Collins

Breast Surgical Onc · MetroHealth

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View

Dr. Monica Bertagnolli

Surgical Oncology · Harvard Medical School

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JPDr. Jennifer Plichta
    Leading Voice

    Dr. Jennifer Plichta

    Surgery · Breast Surgical Oncology
    Duke Medical Center
    jenniferp

    Research

    Trends in Axillary Lymph Node Dissection After Mastectomy Among Patients With Limited Nodal Burden.

    2025

    Via JAMA Network Open

    Research

    Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.

    2025

    Via JCO Clinical Cancer Informatics

    Jan 4, 2025Journal Article

    Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.

    ​

    Written by 1 Roon author & 6 others

    Via Annals of Surgical Oncology
    May 1, 2025Journal Article

    ACR Appropriateness Criteria® Imaging of Ductal Carcinoma in Situ (DCIS).

    ​

    Written by 1 Roon author & 14 others

    Via Journal of the American College of Radiology

    Research

    Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.

    2025

    Via Cancer

    Research

    High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.

    2025

    Via Breast Cancer Research and Treatment

    Research

    ERBB2-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer.

    2025

    Via JAMA Network Open

    Jun 6, 2025Journal Article

    Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.

    ​

    Written by 1 Roon author & 8 others

    Via Annals of Surgical Oncology

    Research

    Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

    2025

    Via Journal of Clinical Oncology

    Research

    ASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage Breast Cancer.

    2025

    Via Annals of Surgical Oncology

    Research

    Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study.

    2025

    Via Breast Cancer Research and Treatment

    Research

    Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study.

    2025

    Via EClinicalMedicine

    May 20, 2025Journal Article

    A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.

    ​

    Written by 1 Roon author & 16 others

    Via Annals of Surgical Oncology

    Research

    The association of race and ethnicity with risk-reducing mastectomies in patients with non-BRCA mutations.

    2025

    Via American Journal of Surgery

    Sep 20, 2025Journal Article

    Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.

    ​

    Written by 1 Roon author & 8 others

    Via Annals of Surgical Oncology